MKI67 and cancer: Percentages of Ki67-positive cells in Luminal A cancers were significantly lower compared to Luminal B and HER2-Enriched cancers (p < 0.01), while polytypic cancers showed lower Ki67+% compared to Luminal B cancers only (p < 0.01) (Fig. 1F).